The c.341G\>T (p.G114V) variant of the prion protein gene (*PRNP*) has been reported in a Uruguayan and a Chinese family to cause an inheritable prion disease, albeit with incomplete penetrance. The condition is characterized by early-onset, relatively prolonged course, early neuropsychiatric symptoms, followed by pyramidal and extrapyramidal symptoms. We present a 20-year-old African American woman, with no family history of neurodegenerative disease, who presented with rapidly progressive cognitive decline and subsequent movement disorders who was found to have the *PRNP* variant.

Case report {#s1}
===========

A 20-year-old African American woman presented with a history of truncus arteriosus (surgically corrected early in life), and years later, she required a porcine pulmonary valve replacement. Her mother and father, ages 51 and 49, respectively, are alive and well. Her brother is 23 years old and has no medical issues. Her maternal and paternal grandparents reached their ninth decades of life without neurodegenerative disease. She presented to the clinic with involuntary movements. In the months prior, she had developed cognitive decline leading to her failing classes in college. On examination, she was found to have a paucity of spontaneous speech output and bradyphrenia and had an incongruent smiling facial expression. Facial myoclonic jerks were noted as was asymmetric action and postural tremor (affecting her left more than her right arm). Her gait was slow, and she had decreased arm swing bilaterally. She was admitted to the hospital for evaluation of reversible causes of rapidly progressive dementia and prion disease.

Electroencephalography revealed diffuse delta frequency slowing without epileptiform activity. Lumbar puncture and CSF analysis showed no inflammatory cells, normal glucose, and elevated protein levels. Autoimmune and paraneoplastic encephalopathy workup was unremarkable. An empiric course of pulse IV methylprednisolone was tried with no notable improvement. Brain MRI ([figure, A and B](#F1){ref-type="fig"}) demonstrated findings typical of prion disease. CSF and blood samples were sent to the Case Western Prion Lab for analysis where the c.341G\>T (p.G114V) variant of the *PRNP* gene was detected.

![MRI of the brain with findings typical of prion disease\
Diffusion weighted imaging (A) and apparent diffusion coefficient (B) MRI brain sequences showing abnormal signal in the cortex diffusely and striatum bilaterally.](NG2017007005FF1){#F1}

One month later, in the clinic, the patient was noted to have more diffuse myoclonic jerks, now involving the extremities as well as her face. Another month passed, and the patient began falling and developed a more cautious gait. She developed emotional lability and would spontaneously cry alternating with irritability. It is interesting to note that such lability (including the inappropriate euphoria described early in her disease course) had been noted in Kuru, leading to the euphemisms "laughing disease" or "laughing death.^[@R1]^" Clonazepam was started to help with myoclonus, anxiety, and irritability.

Discussion {#s2}
==========

The inherited prion diseases, including familial Creutzfeldt-Jakob Disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia, are autosomal dominant in inheritance and are attributable to mutations in the *PRNP* gene. The c.341G\>T (p.G114V) *PRNP* variant was initially reported in members of a Uruguayan family in 2005.^[@R2]^ In 2008, the same variant was reported in a Chinese family.^[@R3],[@R4]^

In the Uruguayan cohort, 4 family members carried the variant and manifested the disease, and 2 family members carried the variant without neurologic signs. Age at onset ranged from 18 to 27 years, and the disease duration ranged from 1 to 4 years. The disease presented with neuropsychiatric disturbances, followed by dementia, parkinsonism, pyramidal signs, myoclonus, and cerebellar signs. In the Chinese cohort, 15 family members were found to carry a heterozygous G114V mutation with 4 affected individuals. The age at onset ranged from 32 to 47 years, with a disease duration of 2--3 years. The clinical presentation was similar to that of the Uruguayan cohort.

Our patient is an African American woman with inherited CJD found to have the rarely reported c.341G\>T (p.G114V) *PRNP* variant. This finding strengthens the evidence that this variant is pathogenic in causing CJD and expands the possible ethnic backgrounds where this variant may be found. Without genetic information from the patient\'s parents, we cannot determine whether this represents a sporadic mutation or whether this provides further evidence for the incomplete penetrance of the variant. A high index of suspicion should be held for a diagnosis of CJD in a patient with rapidly progressive dementia, even in a young adult patient.
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